Live Quote · NASDAQKLRSHealthcare· Biotechnology

Kalaris Therapeutics Inc

$1.28▼ 5.19%($-0.07)
MKT CAP $30.47MNEXT EARNINGS Mar 16, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
100
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KLRS research report →

Analyst Price Target
$18.25+1325.8% vs. today

Range $14 – $23

Analyst RatingBuy
1 Buy0 Hold0 Sell

Price Chart

-81.45% · this period
$10.98$6.13$1.28Nov 20May 26Nov 20
52-Week Range0% of range
Low
$1.25
Current
$1.28
High
$11.88